[2] Common examples available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro), which is a dual GLP-1 and GIP receptor agonist
Mounjaro controls type 2 diabetes but does not cure it
Clinical trials of GLP-1 and related incretin-based medications have shown meaningful average weight loss over longer treatment periods, depending on the medication, dose, study population, adherence, and duration of therapy
Should I avoid certain foods completely
And if youre a student, even betterstudents can access a free version of Pharmacists Letter